Logo

GVK Bio Inks Distribution Deal for Taiwan

Feb 26, 2013 | staff reporter

NEW YORK (GenomeWeb News) – Indian contract research organization GVK Biosciences today announced a distribution deal with Genesis Genetics Asia covering Taiwan.

Under the terms of the deal, GGA will GVK Bio's distributor of its SAR, Biomarker, and Clinical Outcomes databases. The Taiwanese firm will also promote GVK's BioIT and Data Curation services.

Financial and other terms were not disclosed.

GVK said earlier this month that it extended its Clinical Biomarker Database license to Biomarker Qualification Group of the US Food and Drug Administration.

Filed under

Informatics
Business News
licensing agreement
database
GVK Biosciences
Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.